Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents)
  4. Fast Track Articles
  5. Fast Track Article
image of Thiazolidine-4-one Analogues: Synthesis, In-Silico Molecular Modeling, and In-vivo Estimation for Anticonvulsant Potential

Abstract

Background

Epilepsy is a critically deep-rooted CNS disorder affecting above 50 million people all over the world. Thus, a safe and effective treatment that proves its worth in this ailment is urgently needed. Thiazolidine-4-ones possess the molecules to be used as anticonvulsants. The thiazolidinedione is a cyclic analogue of thiosemicarbazides and thioureas as well as a (bio)isostere of hydantoin (imidazolidine-2,4-dione), which are recognized as novel anticonvulsant designs.

Aim

This study aimed to develop and evaluate a novel thiazolidine-4-one derivative by three-component condensation in one pot reaction method.

Methods

A novel thiazolidine-4-one derivative was formulated by three-component condensation. The selected OH (Alcohol) derivatives were found to be more potent; hence, a molecular docking study against a selected target LGI1 LRR domain was performed. Various analytical tests like FTIR and H1 NMR were accomplished. The FTIR was used to validate the existence of multiple functional moieties like C-S, O-H, C=O, C-N, N=O, C-NH, C-O in the wave region from 3075 cm-1 – 1236 cm-1 and H1 NMR was employed to ascertain if the synthesized analogues had the complete set of protons. Then, the anti-seizure activity of the selected compound was examined using PTZ models in mice at three successive doses, , 25, 50, and 100mg/kg, and compared with standard ethosuximide.

Results

The docking simulations were initiated using PyMOL after the binding site was determined and the receptor and ligand were suitably prepared. It showed higher binding frequency in comparison to the standard marketed drug Ethosuximide. FTIR and H1 NMR spectroscopy were used to characterize the chemical components. Numerous functional groups, including O-H (alcohol), C=O (ketones), N=O, C-NH, C-N, C-S, and C-O bending stretching, were visible in the synthesized molecule accordingly. The synthesized compound was effective in inhibiting the convulsions at the concentration of 100 mg/kg.

Conclusion

The novel thiazolidine-4-one derivative showed promising activity and could be considered for further investigation and dosage form preparation.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnsamc/10.2174/0118715249322920241004113343
2024-10-22
2024-11-22

  • From This Site

    /content/journals/cnsamc/10.2174/0118715249322920241004113343
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Mech D. Kurowska A. Trotsko N. The Bioactivity of Thiazolidin-4-Ones: A Short Review of the Most Recent Studies. Int. J. Mol. Sci. 2021 22 21 11533 10.3390/ijms222111533 34768964
    [Google Scholar]
  2. Gawrońska-Grzywacz M. Popiołek Ł. Natorska-Chomicka D. Piątkowska-Chmiel I. Izdebska M. Herbet M. Iwan M. Korga A. Dudka J. Wujec M. Novel 2,3‑disubstituted 1,3‑thiazolidin‑4‑one derivatives as potential antitumor agents in renal cell adenocarcinoma. Oncol. Rep. 2018 41 1 693 701 10.3892/or.2018.6800 30365115
    [Google Scholar]
  3. Ghafoori H. Rezaei M. Mohammadi A. Anti-inflammatory Effects of Novel Thiazolidinone Derivatives as Bioactive Heterocycles on RAW264.7 Cells. Iran. J. Allergy Asthma Immunol. 2017 16 1 28 38 28417622
    [Google Scholar]
  4. Mandal M.K. Ghosh S. Naesens L. Bhat H.R. Singh U.P. Facile synthesis, antimicrobial and antiviral evaluation of novel substituted phenyl 1,3-thiazolidin-4-one sulfonyl derivatives. Bioorg. Chem. 2021 114 105153 10.1016/j.bioorg.2021.105153 34328851
    [Google Scholar]
  5. Beghi E. Giussani G. Sander J.W. The natural history and prognosis of epilepsy. Epileptic Disord. 2015 17 3 243 253 10.1684/epd.2015.0751 26234761
    [Google Scholar]
  6. Abhinit M. Ghodke M. Pratima N. A. ChemInform Abstract: Exploring Potential of 4-Thiazolidinone. ChemInform 2010 41 35 10.1002/chin.201035248
    [Google Scholar]
  7. Gashimova U. Histological Examination of Retinal Function and the Effects of Curcuma longa on Memory Correction in Experimental Olfactory Bulbectomy Rat Models. Adv Bio Earth Sci 2024 9 1 216 222 10.62476/abes9216
    [Google Scholar]
  8. Mishra A.K. Pandey M. Pannu A. Dewangan H.K. Sahoo P.K. Review on Diabetes Mellitus: An Insight into the Current Scenarios, the Challenges of Therapy, and Application of Traditional Drugs. Curr. Tradit. Med. 2024 10 3 e010523216399 10.2174/2215083810666230501212125
    [Google Scholar]
  9. Potschka H. Pharmacological treatment strategies: Mechanisms of antiepileptic drugs. Epileptology 2013 1 1 31 37 10.1016/j.epilep.2012.11.004
    [Google Scholar]
  10. Patrick E. Maibach H.I. Burkhalter A. Mechanisms of chemically induced skin irritation I. Studies of time course, dose response, and components of inflammation in the laboratory mouse. Toxicol. Appl. Pharmacol. 1985 81 3 476 490 10.1016/0041‑008X(85)90419‑3 4082196
    [Google Scholar]
  11. Jubie S. Gowramma B. Kalirajan R. Gomathy S. Elango K. Synthesis and Biological Evaluation of Some 3-Derivatives. Asian J. Res. Chem 2009 1 1 32 38
    [Google Scholar]
  12. Mishra A.K. Neha S.L. Rani L. Jain A. Dewangan H.K. Sahoo P.K. Rationally designed nanoparticulate delivery approach for silymarin with natural bio-enhancer: In vitro characterization and in vivo evaluations of hepatoprotective effects in a mouse model. J. Drug Deliv. Sci. Technol. 2023 86 104580 10.1016/j.jddst.2023.104580
    [Google Scholar]
  13. Baran M.F. Keskin C. Baran A. Hatipoğlu A. Yildiztekin M. Küçükaydin S. Kurt K. Hoşgören H. Sarker M.M.R. Sufianov A. Beylerli O. Khalilov R. Eftekhari A. Green Synthesis of Silver Nanoparticles from Allium cepa L. Peel Extract, Their Antioxidant, Antipathogenic, and Anticholinesterase Activity. Molecules 2023 28 5 2310 10.3390/molecules28052310 36903556
    [Google Scholar]
  14. Miryusifova K. The Saffron Effects on the Dynamics of Experimental Epilepsy. Adv Bio Earth Sci 2024 9 1 196 202 10.62476/abes9196
    [Google Scholar]
  15. Sharma A.N. Dewangan H.K. Upadhyay P.K. Comprehensive Review on Herbal Medicine: Emphasis on Current Therapy and Role of Phytoconstituents for Cancer Treatment. Chem. Biodivers. 2024 21 3 e202301468 10.1002/cbdv.202301468 38206170
    [Google Scholar]
  16. Baran A. Baran M.F. Keskin C. Kandemir S.I. Valiyeva M. Mehraliyeva S. Khalilov R. Eftekhari A. Ecofriendly/Rapid Synthesis of Silver Nanoparticles Using Extract of Waste Parts of Artichoke (Cynara scolymus L.) and Evaluation of their Cytotoxic and Antibacterial Activities. J. Nanomater. 2021 2021 1 10 10.1155/2021/2270472
    [Google Scholar]
  17. Sharma A.N. Upadhyay P.K. Dewangan H.K. Development, evaluation, pharmacokinetic and biodistribution estimation of resveratrol-loaded solid lipid nanoparticles for prostate cancer targeting. J. Microencapsul. 2022 39 6 563 574 10.1080/02652048.2022.2135785 36222429
    [Google Scholar]
  18. Lakshmi S. Singh S. Shah K. Dewangan H.K. Dual Vinorelbine bitartrate and Resveratrol loaded polymeric aqueous core nanocapsules for synergistic efficacy in breast cancer. J. Microencapsul. 2022 39 4 299 313 10.1080/02652048.2022.2070679 35470755
    [Google Scholar]
  19. Jagadeesh M. Kumar V.A. Ramachandraiah C. Reddy A.V. New Halogenated Thiosemicarbazones as Potential Antimicrobial Agents: Synthesis and Spectral Characterization. J. Appl. Pharm. Sci. 2013 3 7 111 115 10.7324/JAPS.2013.3721
    [Google Scholar]
  20. Havrylyuk D. Mosula L. Zimenkovsky B. Vasylenko O. Gzella A. Lesyk R. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Eur. J. Med. Chem. 2010 45 11 5012 5021 10.1016/j.ejmech.2010.08.008 20810193
    [Google Scholar]
  21. Yamagata A. Miyazaki Y. Yokoi N. Shigematsu H. Sato Y. Goto-Ito S. Maeda A. Goto T. Sanbo M. Hirabayashi M. Shirouzu M. Fukata Y. Fukata M. Fukai S. Structural basis of epilepsy-related ligand–receptor complex LGI1–ADAM22. Nat. Commun. 2018 9 1 1546 10.1038/s41467‑018‑03947‑w 29317637
    [Google Scholar]
  22. Deepika D. Dewangan H.K. Maurya L. Singh S. Intranasal Drug Delivery of Frovatriptan Succinate–Loaded Polymeric Nanoparticles for Brain Targeting. J. Pharm. Sci. 2019 108 2 851 859 10.1016/j.xphs.2018.07.013 30053555
    [Google Scholar]
  23. Dewangan H.K. Pandey T. Maurya L. Singh S. Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers. Int. J. Biol. Macromol. 2018 111 804 812 10.1016/j.ijbiomac.2018.01.073 29343454
    [Google Scholar]
  24. Sharma V. Dewangan H.K. Maurya L. Vats K. Verma H. Singh S. Rational design and in-vivo estimation of Ivabradine Hydrochloride loaded nanoparticles for management of stable angina. J. Drug Deliv. Sci. Technol. 2019 54 101337 101346 10.1016/j.jddst.2019.101337
    [Google Scholar]
  25. Mittal P. Goswami M. Airi M. Phytochemical, FTIR and NMR Analysis of Crude Extract of Pogostemon benghalensis Leaves. Plant Cell Biotechnol. Mol. Biol. 2020 21 17–18 212 217
    [Google Scholar]
  26. Sałat K. Kulig K. Sałat R. Filipek B. Malawska B. Analgesic and anticonvulsant activity of new derivatives of 2-substituted 4-hydroxybutanamides in mice. Pharmacol. Rep. 2012 64 1 102 112 10.1016/S1734‑1140(12)70736‑3 22580526
    [Google Scholar]
  27. Velísek L. Velísková J. Anticonvulsant action of carbonic anhydrase inhibition. Sb Lek 1994 95 3 161 71 8711346
    [Google Scholar]
  28. Dewangan H.K. Singh N. Kumar Megh S. Singh S. Lakshmi Optimisation and evaluation of Gymnema sylvestre extract loaded polymeric nanoparticles for enhancement of in vivo efficacy and reduction of toxicity. J. Microencapsul. 2022 39 2 125 135 10.1080/02652048.2022.2051625 35282781
    [Google Scholar]
  29. Yadav R.K. Shah K. Dewangan H.K. Intranasal drug delivery of sumatriptan succinate-loaded polymeric solid lipid nanoparticles for brain targeting. Drug Dev. Ind. Pharm. 2022 48 1 21 28 10.1080/03639045.2022.2090575 35703403
    [Google Scholar]
  30. Shiven A. Alam A. Dewangan H.K. Shah K. Alam P. Kapoor D.N. Optimisation and in-vivo evaluation of extracted Karanjin loaded liposomal topical formulation for treatment of psoriasis in tape-stripped mouse model. J. Microencapsul. 2024 41 5 345 359 10.1080/02652048.2024.2354249 38780157
    [Google Scholar]
/content/journals/cnsamc/10.2174/0118715249322920241004113343
Loading
Thiazolidine-4-one Analogues: Synthesis, In-Silico Molecular Modeling, and In-vivo Estimation for Anticonvulsant Potential
Bentham Science Publishers ; https://doi.org/10.2174/0118715249322920241004113343
/content/journals/cnsamc/10.2174/0118715249322920241004113343
/content/journals/cnsamc/10.2174/0118715249322920241004113343
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Epilepsy ; H1 NMR ; Thiazolidine-4-ones ; docking ; FTIR ; hydantoin ; PTZ

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test